MPL Antikörper
-
- Target Alle MPL Antikörper anzeigen
- MPL (Myeloproliferative Leukemia Virus Oncogene (MPL))
-
Reaktivität
- Maus, Ratte
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser MPL Antikörper ist unkonjugiert
-
Applikation
- Immunohistochemistry (IHC), Immunofluorescence (IF)
- Kreuzreaktivität
- Ratte
- Aufreinigung
- Affinity purification
- Immunogen
- KLH conjugated Synthetic peptide corresponding to Mouse TPOR
- Top Product
- Discover our top product MPL Primärantikörper
-
anti-Myeloproliferative Leukemia Virus Oncogene (MPL) (AA 66-260) antibody
MPL Reaktivität: Maus WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Myeloproliferative Leukemia Virus Oncogene (MPL) antibodyMPL Reaktivität: Human WB, ELISA, FACS Wirt: Maus Monoclonal 1H2 unconjugated
anti-Myeloproliferative Leukemia Virus Oncogene (MPL) (AA 26-175) antibodyMPL Reaktivität: Human WB, ELISA, FACS, IHC, ICC, Neut Wirt: Maus Monoclonal 1D6B7 unconjugated
anti-Myeloproliferative Leukemia Virus Oncogene (MPL) (AA 311-460) antibodyMPL Reaktivität: Human WB, ELISA, IHC (p), ICC, IHC (fro) Wirt: Kaninchen Polyclonal unconjugated
anti-Myeloproliferative Leukemia Virus Oncogene (MPL) (AA 26-491) antibodyMPL Reaktivität: Human ELISA, IHC, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Myeloproliferative Leukemia Virus Oncogene (MPL) (Internal Region) antibodyMPL Reaktivität: Human, Maus, Ratte WB, ELISA, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-Myeloproliferative Leukemia Virus Oncogene (MPL) (AA 1-635) antibodyMPL Reaktivität: Human WB, IP Wirt: Kaninchen Polyclonal unconjugated
anti-Myeloproliferative Leukemia Virus Oncogene (MPL) (AA 1-635) antibodyMPL Reaktivität: Human WB, FACS Wirt: Maus Polyclonal unconjugated
anti-Myeloproliferative Leukemia Virus Oncogene (MPL) antibodyMPL Reaktivität: Human WB Wirt: Kaninchen Monoclonal unconjugated
anti-Myeloproliferative Leukemia Virus Oncogene (MPL) (Extracellular Domain) antibodyMPL Reaktivität: Human WB, FACS Wirt: Maus Monoclonal 1-78-1 unconjugated
-
- Applikationshinweise
- IHC/IF (M,R) 1:500-1:2000
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- PBS, pH 7.4, 0.02 % sodium azide
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
-
- Target
- MPL (Myeloproliferative Leukemia Virus Oncogene (MPL))
- Andere Bezeichnung
- TPOR/MPL (MPL Produkte)
- Synonyme
- C-MPL antikoerper, CD110 antikoerper, MPLV antikoerper, THCYT2 antikoerper, TPOR antikoerper, TPO-R antikoerper, c-mpl antikoerper, c-mpl-I antikoerper, c-mpl-II antikoerper, hlb219 antikoerper, MPL antikoerper, mpll antikoerper, tpor antikoerper, tpor.b antikoerper, MPL proto-oncogene, thrombopoietin receptor antikoerper, myeloproliferative leukemia virus oncogene antikoerper, MPL antikoerper, Mpl antikoerper, mpl antikoerper
- Hintergrund
- The protein encoded by the c-mpl gene, CD110, is a 635 amino acid transmembrane domain, with two extracellular cytokine receptor domains and two intracellular cytokine receptor box motifs . TPO-R deficient mice were severely thrombocytopenic, emphasizing the important role of CD110 and thrombopoietin in megakaryocyte and platelet formation. Upon binding of thrombopoietin CD110 is dimerized and the JAK family of non-receptor tyrosine kinases, as well as the STAT family, the MAPK family, the adaptor protein Shc and the receptors themselves become tyrosine phosphorylated.
- Gen-ID
- 17480
- NCBI Accession
- NP_001116421
- UniProt
- Q08351
- Pathways
- JAK-STAT Signalweg
-
